ENTIS Position Statement: Paracetamol in Pregnancy and Autism Spectrum Disorder
ENTIS does not support the recent claims relating to autism risk following paracetamol use in pregnancy
» Read moreCategory: ENTIS News
Joint EAPCCT-ENTIS Webinar: Clinical approach to poisoning in a pregnant woman. REGISTER TODAY
Presentations from the 36th Annual ENTIS Conference in Thessaloniki are now available in the members area
Members are now able to view the presentation slides from the Thessaloniki conference in the members area (see Presentations from the most recent annual meeting).
» Read more37th ENTIS Meeting Location Announcement
Goodbye to Thessaloniki
Between the 11th and 14th September 2025, Associate Professor Chrysanthi Sardeli (Department of Clinical Pharmacology, Aristotle University of Thessaloniki) welcomed international delegates to the 36th ENTIS conference in the ancient and historic city of Thessaloniki in Greece. The scientific programme was highly engaging, featuring presentations from internationally renown researchers and leaders in the fields of clinical pharmacology, toxicology, pharmacoepidemiology and […]
» Read moreConcePTION project: Milk4baby decision trees published
A sub-study within the ConcePTION project led by researchers from the Swiss Teratology Information Service and the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven in Belgium has resulted in the development of a clinical decision tree to guide researchers in selecting the most appropriate methodological approach for evaluating the safety of medication during breastfeeding. More details about the about […]
» Read moreProspective case series of pregnancy outcomes following gestational CFTR modulator use published
A new collaboration between the Teratology Information Service CRAT (Centre de Reference sur les Agents Tératogènes) and the French Network of Pharmacovigilance Centres has produced the largest to date prospective case series of CFTR modulator exposed pregnancies. The article has been published in the Journal of Cystic Fibrosis, and more details are available here. Photo by Robina Weermeijer on Unsplash
» Read moreCase series of feviparivir exposure in pregnancy published by Terafar Izmir TIS
Researchers from Izmir TIS (Izmir Katip Celebi University Teratology Information Center) have published a case series of 45 pregnancies in women who used feviparivir, More information is available here. Photo by Simon Kadula on Unsplash
» Read moreLatest publications from TIS Paris Cochin
Recent research conducted at TIS Paris Cochin includes: A comprehensive analysis into the safety of ifosfamide in pregnancy, including a review of literature cases, cases in the French pharmacovigilance database, and a disproportionality analysis of Vigibase. A comparative cohort study of pregnancy outcomes following CFTR modulator use in pregnancy. A nationwide cohort study investigating the impact of clomiphene citrate on […]
» Read moreGuidance published on the statistical analysis and reporting of single-arm pregnancy medication safety studies
An open access link to a read only version of the recommendations has been provided by the publisher – see here.
» Read more